Therapy developer Alumis prices U.S. IPO at about $902 mln valuation
Reuters • 599 days
Low Materiality0/10
Information
Alumis set the pricing of its U.S. initial public offering at $16 per share, the lower end of its pr...
Original sourceAI Summary
- Alumis priced its U.S. IPO at $16 per share, valuing the company at around $902 million. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Corporate Developments
Market-Moving
- Alumis priced its U.S. IPO at $16 per share, valuing the company at around $902 million.
Key Facts
- Alumis priced its U.S. IPO at $16 per share, valuing the company at around $902 million.